Dr. Reddy's to Release Q4 and Full Year FY13 Results on May 14, 2013

  Dr. Reddy's to Release Q4 and Full Year FY13 Results on May 14, 2013

         Earnings call slated for May 14, 6.30 PM IST / 9.00 AM EDT*

Business Wire

HYDERABAD, India -- April 30, 2013

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Fourth
Quarter and Full year ended March 31, 2013 on Tuesday, May 14, 2013 after the
Board Meeting. The results will be available on the Company’s website
www.drreddys.com

Summary of Events

Event                  Date and Time (IST)        Medium
Release of             May 14th, after the        Email, Media, Company
financial results         Board Meeting                 website, Business Wire
                          May 14th, 6.30 PM IST /       Hosted by the Company
Earnings Call          9:00 AM EDT               
                                                        (Details below)
                          May 14th, 6.30 PM IST /       URL available on
Webcast of Earnings    9.00 AM EDT through May    Company’s website,
Call                      19th, 2013
                                                        www.drreddys.com
Transcripts of the        Will be available on          URL available on
Earnings call          the Company’s website      Company’s website,
                                                        www.drreddys.com
                                                 

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:              +91 22 6629 0356
Secondary Number:            +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all
countries.
                               6000 1221
                               Available in - Ahmedabad, Bangalore,
                               Bhubaneswar, Chandigarh, Chennai, Coimbatore,
                               Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore,
                               Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur,
                               Kolkata, Nagpur, Noida, Patna, Pune, Raipur,
                               Rajkot, Surat, Trivandrum, Vadodara, Vijayawada

Local Access Number:         Accessible from all major carriers except
                               BSNL/MTNL.

                               3940 3977

                               Available in Ahmedabad, Bangalore, Chandigarh,
                               Chennai, Kochi/Cochin, Gurgaon (NCR),
                               Hyderabad, Kolkata, Lucknow, Pune

                               Accessible from all carriers.
                               USA: 1 866 746 2133

International Toll Free        UK: 0 808 101 1573
Number:                     
                               Singapore: 800 101 2045

                               Hong Kong: 800 964 448
                            

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the
call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at www.drreddys.com. Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through May 19th, 2013. For play
back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's
website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses - Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management and anti-infective. Major markets
include India, USA, Russia-CIS and Europe apart from other select geographies
within Emerging Markets.

For more information, log on to: www.drreddys.com

*EDT- Eastern Daylight Saving Time

Contact:

Dr. Reddy’s Laboratories Ltd.
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 908-203-4931
mkalawadia@drreddys.com
 
Press spacebar to pause and continue. Press esc to stop.